Deltex Medical Share Price | |
---|---|
Price | 0.12 |
Bid | 0.11 |
Ask | 0.13 |
Change | 0.005 (4.35%) |
Volume | 5,663,829 |
Open | 0.115 |
High | 0.12 |
Low | 0.115 |
Prev. Close | 0.115 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 1.90b |
Market Capitalisation | £2.28m |
Market Size | 300,000 |
52 Week High | 1.30 |
52 Week High Date | 01-Jun-2023 |
52 Week Low | 0.095 |
52 Week Low Date | 03-Apr-2024 |
# Trades | 7 |
---|---|
Vol. Sold | 3,346,794 |
Sold Value | £3.78k |
Vol. Bought | 2,317,035 |
Bought Value | £2.72k |
PE Ratio | -1.090909 |
Earnings | -0.11 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
28-May-24 | 15:56:53 | 0.127 | 182,074 | Buy* | 0.11 | 0.13 | 231.23 | O Ordinary |
28-May-24 | 15:40:03 | 0.119 | 835,294 | Sell* | 0.11 | 0.13 | 994.00 | O Ordinary |
28-May-24 | 12:30:30 | 0.111 | 2,500,000 | Sell* | 0.11 | 0.13 | 2,775 | O Ordinary |
28-May-24 | 12:27:06 | 0.11 | 6,500 | Sell* | 0.11 | 0.13 | 7.15 | O Ordinary |
28-May-24 | 09:44:22 | 0.1194 | 500,000 | Buy* | 0.11 | 0.12 | 597.00 | O Ordinary |
28-May-24 | 09:08:55 | 0.11 | 5,000 | Sell* | 0.11 | 0.12 | 5.50 | O Ordinary |
28-May-24 | 08:08:48 | 0.1158 | 1,634,961 | Buy* | 0.11 | 0.12 | 1,893 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Jul-21 | 14-Jul-21 | Placing | Christopher Michael Jones held the position of Non-Executive Director at the time of this trade.Christopher Michael Jones | 1.75 | GBX | 1,371,429 | 4,297,291 |
16-Jul-21 | 14-Jul-21 | Placing | Nigel J Keen held the position of Chairman at the time of this trade.Nigel J Keen | 1.75 | GBX | 2,167,535 | 79,852,821 |
16-Jul-21 | 14-Jul-21 | Placing | Mark Wippell held the position of Non-Executive Director at the time of this trade.Mark Wippell | 1.75 | GBX | 1,371,429 | 10,237,875 |
16-Jul-21 | 14-Jul-21 | Placing | Charles Julian Cazalet held the position of Non-Executive Director at the time of this trade.Charles Julian Cazalet | 1.75 | GBX | 1,371,429 | 17,153,971 |
09-Feb-21 | 08-Feb-21 | Transfer To | Andy Mears held the position of CEO at the time of this trade.Andy Mears | 1.30 | GBX | 3,076,923 | 5,858,731 |
Leading fluid management and cardiac output monitoring systems. A single platform, TrueVue™ with ODM+, measuring flow and pressure directly.